In this issue:
- Neoadjuvant relatlimab + nivolumab in resectable melanoma
- Adjuvant nivolumab + ipilimumab in resected stage IV melanoma
- Neoadjuvant cemiplimab for cutaneous SCC
- Pembrolizumab as adjuvant therapy in resected stage IIB or IIC melanoma
- Prognosis of primary melanoma stage I and II
- Patient education on scarring after Mohs surgery
- Mortality after delays in surgical treatment of melanoma
- Assessment of melanoma thickness based on dermoscopy images
- Topical hypericin photodynamic therapy for cutaneous T-cell lymphoma
- Curettage vs cryosurgery for superficial BCC
Please login below to download this issue (PDF)